InfuSystem Holdings (INFU) Change in Accured Expenses (2010 - 2026)
InfuSystem Holdings (INFU) reported Change in Accured Expenses of -$3.3 million for Q1 2026, down 111.03% on a YoY basis from $30.2 million in Q1 2025, and down 478.78% quarter-over-quarter from -$575000.0 in Q4 2025.
InfuSystem Holdings (INFU) Change in Accured Expenses (2010 - 2026) Analysis & Trends
InfuSystem Holdings has reported Change in Accured Expenses for 11 years, with the latest figure at -$3.3 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Accured Expenses fell 111.03% year-over-year to -$3.3 million; the trailing twelve-month figure through Mar 2026 stood at -$2.5 million (down 114.39% YoY), and the FY2025 full-year result was -$708000.0, down 4.73% from the prior year.
- Change in Accured Expenses for Q1 2026 stood at -$3.3 million, down from -$575000.0 in the prior quarter.
- The five-year high for Change in Accured Expenses was $2.7 million in Q4 2023, with the low at -$3.3 million in Q1 2026.
- Historically, Change in Accured Expenses has averaged $37941.2 across 5 years, with a median of $313000.0 in 2023.
- Annual changes were most pronounced in 2022 — Change in Accured Expenses surged 194.16% — and 2024, when it slumped 453.35%.
- InfuSystem Holdings' Change in Accured Expenses stood at $1.7 million in 2022, then jumped by 55.22% to $2.7 million in 2023, then sank by 79.55% to $553000.0 in 2024, then slumped by 203.98% to -$575000.0 in 2025, then sank by 478.78% to -$3.3 million in 2026.
- The last three Change in Accured Expenses figures came in at -$3.3 million (Q1 2026), -$575000.0 (Q4 2025), and $1.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 703.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 21.07 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 145.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -250.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 74.30 Mn |
| 10 | InfuSystem Holdings | 189.78 Mn | 187.68 Mn | 19.68 Mn | -3.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.33 Mn |
| Mar 31, 2026 | -3.33 Mn |
| Dec 31, 2025 | -575,000.00 |
| Dec 31, 2025 | -575,000.00 |
| Sep 30, 2025 | 1.84 Mn |
| Sep 30, 2025 | 1.84 Mn |
| Jun 30, 2025 | -398,000.00 |
| Jun 30, 2025 | -398,000.00 |
| Mar 31, 2025 | -1.58 Mn |
| Mar 31, 2025 | -1.58 Mn |
| Dec 31, 2024 | 553,000.00 |
| Dec 31, 2024 | 553,000.00 |
| Sep 30, 2024 | 2.04 Mn |
| Sep 30, 2024 | 2.04 Mn |
| Jun 30, 2024 | -2.16 Mn |
| Jun 30, 2024 | -2.16 Mn |
| Mar 31, 2024 | -1.11 Mn |
| Mar 31, 2024 | -1.11 Mn |
| Dec 31, 2023 | 2.70 Mn |
| Dec 31, 2023 | 2.70 Mn |